AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
“Any obesity is a big risk for high blood pressure but, again, abdominal fat is an especially big contributor,” says Chiesa. ...
I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...
In the second episode of The Deep End, listeners hear what it’s like to live with severe depression and the backstory of an experimental treatment.
We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...
The following is a look at some of those who make up what is becoming an alarmingly long list of performers who are dealing with health issues: Iconic singer Michael Bolton’s recent announcement as he ...
The governing body has launched a search for grants to fund research into mental health, anti-doping techniques and ...
This Press Release updates numerical list in reference sectionTheralase® validates previous University of Manitoba research ...
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 60 years ago, Bill Medley, now 84, ...
6d
Zacks.com on MSNBiogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance DisappointsBiogen BIIB reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.44, which beat the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results